Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1224 participants.

Also called NCT06269432

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,224 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06269432
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06269432. Randomized; single masking; primary purpose prevention. Start 2023-01-01 (actual); primary completion 2024-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)
Acronym
PATH-STROKE
Condition
Antiplatelet Drug
Intervention (Drug)
Precision Antiplatelet Therapy Trial Group
Intervention (Drug)
Traditional Antiplatelet Therapy Control Group
Lead sponsor
Sichuan Provincial People's Hospital (class: other)

Record details

Record id
cardio:ct-nct06269432
Content hash
d1ae49f0d0055fdb8bbe38ce2aa4b425ab1614621f2064753971b9dd85c9536f